Trials / Unknown
UnknownNCT05151796
Continuation of Aspirin Before Isolated Heart Valve Surgery
Effect of Continuation of Aspirin Before Isolated Heart Valve Surgery on Postoperative Bleeding and Transfusion: a Single-center Retrospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Whether or not continuing aspirin up to de day before surgery increases the risk of bleeding and/or prevents thrombo-embolic complications remains debated. The investigators retrospectively investigated the whether continuing aspirine within 5 days of isolated heart valve surgery increased the risk of bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin | Daily aspirin intake for cardiovascular prevention |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2017-05-01
- Completion
- 2021-12-01
- First posted
- 2021-12-09
- Last updated
- 2021-12-09
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05151796. Inclusion in this directory is not an endorsement.